Unlocking high-trust insights from clinical specialists, hospital decision-makers, and patient cohorts under strict compliance standards.
We maintain deeply profiled panels of practicing clinicians across key specialties, including oncology, cardiology, neurology, pediatrics, and immunology. Our panelists are verified against national registry databases (e.g. NPI in the US, GMC in the UK) before enrollment.
Reach hospital procurement directors, chief medical officers, health economics outcomes research (HEOR) managers, and formulary committee members. We coordinate high-value quantitative and qualitative studies focusing on medical device purchasing, pricing studies, and pharmaceutical formulary selections.
Through double-blind opt-in partnerships and clinical patient networks, we supply access to verified chronic illness cohorts, caregivers, and rare-disease patient groups, complying with HIPAA patient data sovereignty rules.
All Scrutiny Global clinical projects are governed by rigorous protocols: full HIPAA data encryption pipelines, GDPR compliance, ESOMAR guidelines, and anonymous respondent tracking.
Request Healthcare FeasibilityDownload our dedicated Healthcare Panel Book containing detailed geographical spreads, incidence tables, and specialty counts.
Download Panel Book